<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04987350748188</udiDi>
    <basicUdiDi>498735026TRBDQB</basicUdiDi>
    <tradeName>TR Band Distal</tradeName>
    <deviceName>TR Band Distal</deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C90010301</emdnCode>
    <emdnDescription>HAEMOSTASIS MECHANICAL SYSTEMS (INCLUDING SINGLE-USE TOURNIQUETS)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>XX*RF06D</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-29T20:05:25.708Z</lastUpdated>
  </row>
  <row>
    <udiDi>04987350727909</udiDi>
    <basicUdiDi>498735026ADVTLU</basicUdiDi>
    <tradeName>RADIFOCUS Glidewire Advantage Track</tradeName>
    <deviceName>RADIFOCUS Glidewire Advantage Track</deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C04020201</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR THERAPEUTIC GUIDEWIRES, HYDROPHILIC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RA*GB18181CM</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-29T20:05:06.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>04987350727985</udiDi>
    <basicUdiDi>498735026ADVTLU</basicUdiDi>
    <tradeName>RADIFOCUS Glidewire Advantage Track</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C04020201</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR THERAPEUTIC GUIDEWIRES, HYDROPHILIC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RA*GB14301CM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-29T19:55:03.563Z</lastUpdated>
  </row>
  <row>
    <udiDi>04987350727923</udiDi>
    <basicUdiDi>498735026ADVTLU</basicUdiDi>
    <tradeName>RADIFOCUS Glidewire Advantage Track</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C04020201</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR THERAPEUTIC GUIDEWIRES, HYDROPHILIC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RA*GB18301CM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-29T19:55:03.549Z</lastUpdated>
  </row>
  <row>
    <udiDi>04987350727961</udiDi>
    <basicUdiDi>498735026ADVTLU</basicUdiDi>
    <tradeName>RADIFOCUS Glidewire Advantage Track</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C04020201</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR THERAPEUTIC GUIDEWIRES, HYDROPHILIC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RA*GB14181CM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-29T19:55:03.524Z</lastUpdated>
  </row>
  <row>
    <udiDi>34987350724527</udiDi>
    <basicUdiDi>498735037KH2H</basicUdiDi>
    <tradeName>34987350724527</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>A0101010202</emdnCode>
    <emdnDescription>HYPODERMIC PEN NEEDLES, W/O SAFETY SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TN*32506CC</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T03:41:55.284Z</lastUpdated>
  </row>
  <row>
    <udiDi>34987350724480</udiDi>
    <basicUdiDi>498735037KH2H</basicUdiDi>
    <tradeName>34987350724480</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Terumo Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000017478</manufacturerSrn>
    <authorisedRepresentativeName>TERUMO EUROPE N.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000001433</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>A0101010202</emdnCode>
    <emdnDescription>HYPODERMIC PEN NEEDLES, W/O SAFETY SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TN*32504CC</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T03:41:55.262Z</lastUpdated>
  </row>
</eudamedExport>